/

PHRM.CN

PharmaTherClosed

0.0550−0.00 −8.33%CAD

Canadian Sec · as of Oct 13, 15:58 ET

Open

0.000000

Prev close

0.0600

Day range

0.0000000.000000

52-week range

0.0000000.1600

Mkt cap

5.01M

P/E ttm

—

Fwd P/E

-0.50

EPS ttm

-0.0100

Div yield

0.00%

Earnings

—

From 52w high

−65.63%

Price Chart

Yahoo Finance · delayed

PHRM.CNOct 13, 2026O 0.0550H 0.0550L 0.0550C 0.0550−0.0050 (−8.33%)Vol 5.00K

SMA 500.0551
SMA 2000.0693

1Y change −64.52% since Oct 10, 2025 close539 bars loadedTimes in America/TorontoDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

PHRM.CN PharmaTher · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −15.38%
1 month: +10.00%
3 months: +10.00%
6 months: −15.38%
Year to date: −47.62%
1 year: −64.52%

Valuation & ownership

Market cap: 5.01M
Enterprise value: 4.08M
P/E (ttm): —
Forward P/E: -0.50
PEG ratio: —
Price / book: 7.86
Price / sales (ttm): —
EV / EBITDA: —
EPS (ttm): -0.0100
EPS (forward): -0.1100
Beta (5y monthly): 2.16
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 91.02M
Float: 73.51M
Short % of float: —
Short ratio (days): 0.40
Held by insiders: 18.74%
Held by institutions: 0.00%
Avg volume (3m): 54.73K
50-day average: 0.0551
200-day average: 0.0689
52-week change: −64.52%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): 48.9
vs 50-day SMA: −0.18%
vs 200-day SMA: −20.61%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▲ above
ATR (14) % of price: 5.73%
Realised vol (20d, ann.): 107.3%
From 52-week high: −65.62%
From 52-week low: +22.22%

ANR

Analyst Consensus

No analyst coverage for this instrument.

Financial Snapshot

Full statements →trailing twelve months

Revenue (ttm): —
Revenue growth (yoy): —
Earnings growth (yoy): —
Gross margin: 0.00%
Operating margin: 0.00%
Profit margin: 0.00%

DES

About PharmaTher

Yahoo Finance profile

PharmaTher Holdings Ltd., a specialty pharmaceutical and technology company, develops, acquires, and commercializes pharmaceutical products. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia, procedural sedation as well as depression, surgical and pain management. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX wearable pump for the maintenance of general anesthesia for diagnostic, surgical procedures and pain indications. In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases. The company also develops Personaliz3D Peptides, focused on developing and commercializing personalized peptide products and protocols using 3D printing and artificial intelligence technologies. Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS; with the University of Arizona for the development and commercialization of ketamine in the treatment of Parkinson's disease; as well as holds a patent and know-how license agreement with The Queen's University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology. The company was incorporated in 2019 and is headquartered in Toronto, Canada.

Sector: Healthcare
Industry: Biotechnology
Headquarters: Toronto, ON, Canada
Website: pharmather.com
Officers

SEAS

Seasonality · PHRM.CN

2021–2026 · monthly returns

Strongest month Jun +78.06%Weakest month Oct −28.74%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-14.3	-16.7	-6.7	21.4	-23.5	-23.1	20.0	-8.3	0.0	0.0			−47.6%
2025	0.0	-6.8	2.4	-9.5	10.5	123.8	12.8	-28.3	-2.6	-68.9	0.0	-8.7	−52.3%
2024	-20.6	-10.0	73.3	-32.1	-18.9	-2.3	14.3	-25.0	58.3	-24.6	18.6	-13.7	−30.2%
2023	84.6	25.0	-13.3	-3.8	-12.0	50.0	-6.1	-9.7	10.7	-6.5	13.8	90.9	+384.6%
2022	-19.4	-11.1	-43.7	11.1	0.0	-13.3	3.8	7.4	-13.8	-12.0	-18.2	-27.8	−80.6%
2021					16.7	232.1	15.1	-5.6	-37.6	-31.7	-12.8	-10.7	+39.6%

PHRM.CN

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

PHRM.CN

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About PharmaTher

Seasonality · PHRM.CN

Insider Activity · PHRM.CN

Congress Trades · PHRM.CN

Investors Holding PHRM.CN

Investors Holding PHRM.CN

Congress Trades · PHRM.CN

Insider Activity · PHRM.CN

Seasonality · PHRM.CN

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About PharmaTher

Earnings & Dividends

News